粪便微生物群移植——一种古老的疗法走向成熟。 - Suppr

Suppr

超能文献

Fecal microbiota transplantation--an old therapy comes of age.

作者信息

Kelly Ciarán P

出版信息

N Engl J Med. 2013 Jan 31;368(5):474-5. doi: 10.1056/NEJMe1214816. Epub 2013 Jan 16.

DOI:10.1056/NEJMe1214816

PMID:23323865

Abstract

摘要

相似文献

Fecal microbiota transplantation--an old therapy comes of age.粪便微生物群移植——一种古老的疗法走向成熟。

N Engl J Med. 2013 Jan 31;368(5):474-5. doi: 10.1056/NEJMe1214816. Epub 2013 Jan 16.

Fecal transplantation: beyond the aesthetic.粪便移植：超越美学范畴。

Gastroenterology. 2013 Nov;145(5):1151-3. doi: 10.1053/j.gastro.2013.09.015. Epub 2013 Sep 19.

Duodenal infusion of feces for recurrent Clostridium difficile.粪便十二指肠输注治疗复发性艰难梭菌感染

N Engl J Med. 2013 May 30;368(22):2145. doi: 10.1056/NEJMc1303919.

Duodenal infusion of feces for recurrent Clostridium difficile.粪便十二指肠输注治疗复发性艰难梭菌感染

N Engl J Med. 2013 May 30;368(22):2143. doi: 10.1056/NEJMc1303919.

Duodenal infusion of feces for recurrent Clostridium difficile.十二指肠输注粪便用于复发性艰难梭菌感染

N Engl J Med. 2013 May 30;368(22):2143-4. doi: 10.1056/NEJMc1303919.

Duodenal infusion of feces for recurrent Clostridium difficile.粪便十二指肠输注治疗复发性艰难梭菌感染

N Engl J Med. 2013 May 30;368(22):2144. doi: 10.1056/NEJMc1303919.

Duodenal infusion of feces for recurrent Clostridium difficile.十二指肠输注粪便用于复发性艰难梭菌感染

N Engl J Med. 2013 May 30;368(22):2144. doi: 10.1056/NEJMc1303919.

[Stool transplantation for relapsing Cl. difficile colitis].[粪便移植治疗复发性艰难梭菌结肠炎]

Z Gastroenterol. 2013 Dec;51(12):1441-3. doi: 10.1055/s-0033-1350583. Epub 2013 Dec 11.

Duodenal infusion of stool is more effective than vancomycin in patients with recurrent Clostridium difficile.对于复发性艰难梭菌感染患者，十二指肠注入粪便比万古霉素更有效。

Evid Based Med. 2013 Dec;18(6):220-1. doi: 10.1136/eb-2013-101308. Epub 2013 Apr 24.

Reply: To PMID 23323867.回复：针对 PMID 23323867。

Gastroenterology. 2013 Nov;145(5):1153. doi: 10.1053/j.gastro.2013.09.016. Epub 2013 Sep 19.

引用本文的文献

Fecal microbiota transplantation from postmenopausal osteoporosis human donors accelerated bone mass loss in mice.来自绝经后骨质疏松症人类供体的粪便微生物群移植加速了小鼠的骨质流失。

Front Cell Infect Microbiol. 2024 Dec 5;14:1488017. doi: 10.3389/fcimb.2024.1488017. eCollection 2024.

The efficacy of prevention for colon cancer based on the microbiota therapy and the antitumor mechanisms with intervention of dietary .基于微生物群疗法的结肠癌预防功效以及饮食干预的抗肿瘤机制。

Microbiol Spectr. 2023 Sep 1;11(5):e0018923. doi: 10.1128/spectrum.00189-23.

Toward Understanding Microbial Ecology to Restore a Degraded Ecosystem.理解微生物生态学以恢复退化的生态系统。

Int J Environ Res Public Health. 2023 Mar 6;20(5):4647. doi: 10.3390/ijerph20054647.

Global research trends and hotspots of fecal microbiota transplantation: A bibliometric and visualization study.粪便微生物群移植的全球研究趋势与热点：一项文献计量学与可视化研究

Front Microbiol. 2022 Aug 18;13:990800. doi: 10.3389/fmicb.2022.990800. eCollection 2022.

The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation.供体和受体内肠道微生物群的相互作用决定了粪便微生物群移植的疗效。

Gut Microbes. 2022 Jan-Dec;14(1):2100197. doi: 10.1080/19490976.2022.2100197.

Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors.肠易激综合征粪便微生物群移植方案：MISCEAT 研究——一项使用健康供体混合菌群的随机、双盲交叉研究

BMJ Open. 2022 Jun 27;12(6):e056594. doi: 10.1136/bmjopen-2021-056594.

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease.慢性肾脏病肠-肾-心轴中的肠道微生物群与代谢产物

Front Pharmacol. 2022 Mar 18;13:837500. doi: 10.3389/fphar.2022.837500. eCollection 2022.

Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies.急性肾损伤中的肠道微生物群失调：机制的新见解和有前景的治疗策略。

Ren Fail. 2022 Dec;44(1):571-580. doi: 10.1080/0886022X.2022.2056054.

Clostridioides difficile Infection in Patients with Chronic Kidney Disease: A Systematic Review.艰难梭菌感染与慢性肾脏病：系统综述。

Biomed Res Int. 2021 Sep 13;2021:5466656. doi: 10.1155/2021/5466656. eCollection 2021.

The Human Gut Microbe Suppresses Toxin Release from by Inhibiting Autolysis.人类肠道微生物通过抑制自溶来抑制毒素释放。（你提供的原文“from by”之间似乎缺失了关键信息，我按照合理推测进行了翻译补充，若不准确请提供完整准确原文）

Antibiotics (Basel). 2021 Feb 15;10(2):187. doi: 10.3390/antibiotics10020187.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验